Showing results (1801-1810 of 1,843) with videos related to

Sort By:
Pageof 185
Toxicology in Vitro : an International Journal Published in Association with BIBRA|June 4, 2009
A proposed eye irritation testing strategy to reduce and replace in vivo studies using Bottom-Up and Top-Down approachesLaurie Scott, Chantra Eskes, Sebastian Hoffmann, et al.
Nature|November 11, 2014
mTORC1-mediated translational elongation limits intestinal tumour initiation and growthWilliam J Faller, Thomas J Jackson, John Rp Knight, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2013
Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT networkM Beau-Faller, N Prim, A-M Ruppert, et al.
Nature Communications|June 29, 2026
Discovery of 5' NAD capped viral RNAs reveals evolutionary divergent 5' metabolite capping across hepacivirusesHelena S Larsen, Anna V Sherwood, Lizandro R Rivera-Rangel, et al.
The Journal of Molecular Diagnostics : JMD|November 5, 2013
A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platformsMichèle Beau-Faller, Hélène Blons, Caroline Domerg, et al.
BMC Nephrology|December 12, 2018
Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trialNasser A Dhayat, Nicolas Faller, Olivier Bonny, et al.
The New England Journal of Medicine|March 1, 2023
Hydrochlorothiazide and Prevention of Kidney-Stone RecurrenceNasser A Dhayat, Olivier Bonny, Beat Roth, et al.
Blood Cancer Journal|July 19, 2022
BRD9 degraders as chemosensitizers in acute leukemia and multiple myelomaEllen Weisberg, Basudev Chowdhury, Chengcheng Meng, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2008
BACE-1 inhibitors part 3: identification of hydroxy ethylamines (HEAs) with nanomolar potency in cellsPaul Beswick, Nicolas Charrier, Brian Clarke, et al.
Gynecologic Oncology|June 3, 2025
OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancerPremal H Thaker, Debra L Richardson, Andrea R Hagemann, et al.
Pageof 185